About the journal
Frontiers in Allergy is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,550 CHF. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Frontiers Media S.A.
- ISSN
- 2673-6101
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,550 CHF
- Articles in DOAJ
- 964
- Declared review time
- 12 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.frontiersin.org/journals/allergy
Index listings
- DOAJ · 2021-04-30
- Indexing
- DOAJ
- APC
- 2,550 CHF
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
964
Most recent article
last month
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
919
Last recorded publication year
2026
h-index
34
i10-index
227
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2021-04-30
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 95%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918227355906676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Allergic Rhinitis and Sensitization
- Allergic Rhinitis and Sensitization
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Food Allergy and Anaphylaxis Research
- Food Allergy and Anaphylaxis Research
- Dermatology and Skin Diseases
- Dermatology and Skin Diseases
Show all subjects (50)
- Drug-Induced Adverse Reactions
- Drug-Induced Adverse Reactions
- Sinusitis and nasal conditions
- Sinusitis and nasal conditions
- Contact Dermatitis and Allergies
- Contact Dermatitis and Allergies
- Mast cells and histamine
- Mast cells and histamine
- Eosinophilic Esophagitis
- Eosinophilic Esophagitis
- Urticaria and Related Conditions
- Urticaria and Related Conditions
- IL-33, ST2, and ILC Pathways
- IL-33, ST2, and ILC Pathways
- Respiratory and Cough-Related Research
- Respiratory and Cough-Related Research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Pediatric health and respiratory diseases
- Pediatric health and respiratory diseases
- Olfactory and Sensory Function Studies
- Olfactory and Sensory Function Studies
- Occupational exposure and asthma
- Occupational exposure and asthma
- Gut microbiota and health
- Gut microbiota and health
- Nasal Surgery and Airway Studies
- Nasal Surgery and Airway Studies
- Inhalation and Respiratory Drug Delivery
- Inhalation and Respiratory Drug Delivery
- Eosinophilic Disorders and Syndromes
- Eosinophilic Disorders and Syndromes
- Indoor Air Quality and Microbial Exposure
- Indoor Air Quality and Microbial Exposure
- Respiratory viral infections research
- Psoriasis: Treatment and Pathogenesis
- Pharmacovigilance and Adverse Drug Reactions
- Psoriasis: Treatment and Pathogenesis
- Respiratory viral infections research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pharmacovigilance and Adverse Drug Reactions
- Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords (DOAJ)
- rhinology
- dermatology
- allergy
- allergen
- respiratory diseases
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ